Reversal of Drug Resistance in Ovarian Cancer: Where Do We Go From Here?
Author:
Affiliation:
1. Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, United Kingdom
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2008.16.2123
Reference30 articles.
1. Ovarian cancer: strategies for overcoming resistance to chemotherapy
2. Phase III Study of Valspodar (PSC 833) Combined With Paclitaxel and Carboplatin Compared With Paclitaxel and Carboplatin Alone in Patients With Stage IV or Suboptimally Debulked Stage III Epithelial Ovarian Cancer or Primary Peritoneal Cancer
3. Multidrug Resistance: Molecular Biology Clinical Relevance
4. P glycoprotein (P-gp) and drug resistance – time for reappraisal?
5. Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance.
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Overcoming ABCB1-mediated multidrug resistance by transcription factor BHLHE40;Neoplasia;2023-05
2. Multidrug resistance protein 1 silencing in osteosarcoma and chondrosarcoma cell lines;Journal of Cancer Research and Therapeutics;2023
3. Circumventing Doxorubicin Resistance Using Elastin-like Polypeptide Biopolymer-Mediated Drug Delivery;International Journal of Molecular Sciences;2022-02-19
4. Sulforaphane as a potential remedy against cancer: Comprehensive mechanistic review;Journal of Food Biochemistry;2021-08-05
5. Clinicopathological significance of endoplasmic reticulum stress proteins in ovarian carcinoma;Scientific Reports;2020-02-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3